Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia-myelofibrosis

Shaji K Kumar, Benjamin M F Mow, Scott H Kaufmann

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Hypercalcemia is a common and potentially life-threatening metabolic derangement associated with many malignancies, especially solid tumors and multiple myeloma. Hypercalcemia has been reported only rarely with acute myelogenous leukemia. We describe a patient who developed hypercalcemia in association with transformation of agnogenic myeloid metaplasia into M7 acute myelogenous leukemia. Laboratory investigation revealed low levels of serum parathyroid hormone, undetectable levels of parathyroid hormone-related peptide, and normal levels of 25-hydroxyvitamin D. These observations suggest that an- other mediator was responsible for hypercalcemia in this patient. Awareness of this rare complication of acute myelogenous leukemia is essential for prompt diagnosis and management.

Original languageEnglish (US)
Pages (from-to)1233-1237
Number of pages5
JournalMayo Clinic Proceedings
Volume74
Issue number12
StatePublished - 1999

Fingerprint

Primary Myelofibrosis
Hypercalcemia
Acute Myeloid Leukemia
Parathyroid Hormone-Related Protein
Parathyroid Hormone
Multiple Myeloma
Neoplasms
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia-myelofibrosis. / Kumar, Shaji K; Mow, Benjamin M F; Kaufmann, Scott H.

In: Mayo Clinic Proceedings, Vol. 74, No. 12, 1999, p. 1233-1237.

Research output: Contribution to journalArticle

@article{f06d31a65cf44449b594242a8206faa1,
title = "Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia-myelofibrosis",
abstract = "Hypercalcemia is a common and potentially life-threatening metabolic derangement associated with many malignancies, especially solid tumors and multiple myeloma. Hypercalcemia has been reported only rarely with acute myelogenous leukemia. We describe a patient who developed hypercalcemia in association with transformation of agnogenic myeloid metaplasia into M7 acute myelogenous leukemia. Laboratory investigation revealed low levels of serum parathyroid hormone, undetectable levels of parathyroid hormone-related peptide, and normal levels of 25-hydroxyvitamin D. These observations suggest that an- other mediator was responsible for hypercalcemia in this patient. Awareness of this rare complication of acute myelogenous leukemia is essential for prompt diagnosis and management.",
author = "Kumar, {Shaji K} and Mow, {Benjamin M F} and Kaufmann, {Scott H}",
year = "1999",
language = "English (US)",
volume = "74",
pages = "1233--1237",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "12",

}

TY - JOUR

T1 - Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia-myelofibrosis

AU - Kumar, Shaji K

AU - Mow, Benjamin M F

AU - Kaufmann, Scott H

PY - 1999

Y1 - 1999

N2 - Hypercalcemia is a common and potentially life-threatening metabolic derangement associated with many malignancies, especially solid tumors and multiple myeloma. Hypercalcemia has been reported only rarely with acute myelogenous leukemia. We describe a patient who developed hypercalcemia in association with transformation of agnogenic myeloid metaplasia into M7 acute myelogenous leukemia. Laboratory investigation revealed low levels of serum parathyroid hormone, undetectable levels of parathyroid hormone-related peptide, and normal levels of 25-hydroxyvitamin D. These observations suggest that an- other mediator was responsible for hypercalcemia in this patient. Awareness of this rare complication of acute myelogenous leukemia is essential for prompt diagnosis and management.

AB - Hypercalcemia is a common and potentially life-threatening metabolic derangement associated with many malignancies, especially solid tumors and multiple myeloma. Hypercalcemia has been reported only rarely with acute myelogenous leukemia. We describe a patient who developed hypercalcemia in association with transformation of agnogenic myeloid metaplasia into M7 acute myelogenous leukemia. Laboratory investigation revealed low levels of serum parathyroid hormone, undetectable levels of parathyroid hormone-related peptide, and normal levels of 25-hydroxyvitamin D. These observations suggest that an- other mediator was responsible for hypercalcemia in this patient. Awareness of this rare complication of acute myelogenous leukemia is essential for prompt diagnosis and management.

UR - http://www.scopus.com/inward/record.url?scp=0032758777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032758777&partnerID=8YFLogxK

M3 - Article

C2 - 10593353

AN - SCOPUS:0032758777

VL - 74

SP - 1233

EP - 1237

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 12

ER -